🇺🇸 FDA

Company profile · Sponsor

Blue

Blue Earth Diagnostics Ireland Ltd

EB40AA5 · EMA pharma GB
Pipeline
11
Drugs
0
Patents
0

Quick answer

Blue (EB40AA5) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 11 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EB40AA5
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (11)

Search pipeline →

  1. BJT-778

    Blue

    Chronic Hepatitis Delta Infection

    phase 3 small molecule active

    1 trial

  2. BJT-778

    Blue

    Chronic Hepatitis Delta Infection

    phase 3 small molecule active

    1 trial

  3. BULEVIRTIDE, BJT-778

    Blue

    Chronic Hepatitis D Infection

    phase 3 small molecule active

    1 trial

  4. BULEVIRTIDE, BJT-778

    Blue

    Chronic Hepatitis D Infection

    phase 3 small molecule active

    1 trial

  5. BFB759, Placebo

    Blue

    Atopic dermatitis

    phase 2 small molecule active

    1 trial

  6. Lutetium (177Lu) rhPSMA-10.1 injection

    Blue

    Metastatic castration-resistant prostate cancer (mCRPC)

    phase 2 small molecule active

    1 trial

  7. Placebo, BFB759

    Blue

    Hidradenitis Suppurativa

    phase 2 small molecule active

    1 trial

  8. [68Ga]BED003 injection

    Blue

    Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).

    phase 2 small molecule active

    1 trial

  9. A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma

    Blue

    Treatment of human papilloma virus (HPV) associated infections and cancers

    phase 1 other active

    1 trial

  10. A study of different dose levels of FluBHPVE6E7 or placebo in women infected with the virus Human Papilloma Type 16 (HPV 16).

    Blue

    Treatment of human papilloma virus (HPV) associated infections, precancers and cancers

    phase 1 other active

    1 trial

  11. Pluvicto 1 000 MBq/mL solution for injection/infusion, Lutetium (177Lu) rhPSMA-10.1 injection

    Blue

    PSMA-positive non-curative metastatic castration-resistant prostate cancer

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Blue?

Blue (EB40AA5) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 11 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Blue sponsor?

We track 11 ClinicalTrials.gov-linked programs for Blue, including BJT-778 and 10 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Blue company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.